Group 1 - Tianzhihang Medical Technology Co., Ltd. is focused on the research, production, sales, and service of orthopedic surgical navigation robots, with a revenue composition of 58.31% from these robots, 23.86% from supporting equipment and consumables, 16.49% from technical services, and 1.31% from other sources [1] - As of February 27, Tianzhihang's stock price increased by 5.11% to 25.92 CNY per share, with a trading volume of 224 million CNY and a turnover rate of 1.98%, resulting in a total market capitalization of 11.819 billion CNY [1] Group 2 - Huayin Fund Management has one fund heavily invested in Tianzhihang, specifically the Huayin Health Life Theme Flexible Allocation Fund (001056), which reduced its holdings by 30,000 shares in the fourth quarter, maintaining 200,000 shares, representing 4.01% of the fund's net value [2] - The Huayin Health Life Theme Flexible Allocation Fund has achieved a year-to-date return of 20.43%, ranking 364 out of 8,891 in its category, and a one-year return of 23.33%, ranking 4,141 out of 8,137 [2]
天智航股价涨5.11%,华银基金管理旗下1只基金重仓,持有20万股浮盈赚取25.2万元